ESC Premium Access

2016 update on LDL as a risk factor.

Congress Presentation

About the speaker

Professor Lale Tokgozoglu

Hacettepe University, Ankara (Türkiye)
37 presentations
3 followers

3 more presentations in this session

Status of CVD Health and cholesterol in Europe

Speaker: Doctor S. Sans Menendez (Barcelona, ES)

Thumbnail

PCSK9 inhibition: The new player in the field.

Speaker: Professor D. Ural (Istanbul, TR)

Thumbnail

The future of LDL lowering Recent data from PCSK9 inhibitors and outlook for upcoming trials.

Speaker: Professor U. Landmesser (Berlin, DE)

Thumbnail

Access the full session

LDL-Cholesterol lowering at a turning point

Speakers: Professor L. Tokgozoglu, Doctor S. Sans Menendez, Professor D. Ural, Professor U. Landmesser
Thumbnail

About the event

Image

EuroPRevent Meeting 2016

14 June - 15 June 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb